✦ LIBER ✦

Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK1 receptor antagonist

✍ Scribed by R. Cirillo; M. Astolfi; B. Conte; G. Lopez; M. Parlani; G. Sacco; R. Terracciano; C.I. Fincham; A. Sisto; S. Evangelista; C.A. Maggi; S. Manzini

Book ID: 114484913
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 183 KB
Volume: 35
Category: Article
ISSN: 0143-4179
DOI: 10.1054/npep.2001.0855

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the peptidomimetic, MEN

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist

✍ Rocco Cirillo; Mara Astolfi; Bruno Conte; Giuseppe Lopez; Massimo Parlani; Rosa 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Discovery of a New Series of Potent and

Discovery of a New Series of Potent and Selective Linear Tachykinin NK 2 Receptor Antagonists

✍ Fedi, Valentina; Altamura, Maria; Catalioto, Rose-Marie; Giannotti, Danilo; Giol 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 300 KB

Biochemical and pharmacological activiti

Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist

✍ X Emonds-Alt; C Advenier; C Cognon; T Croci; S Daoul; J.P Ducoux; M Landi; E Nal 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 975 KB

Improved discriminatory properties betwe

Improved discriminatory properties between human and murine tachykinin NK1 receptors of MEN 10930: a new potent and competitive antagonist

✍ M Astolfi; R Patacchini; M Maggi; S Manzini 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 683 KB

The airways pharmacology of DNK333, a po

The airways pharmacology of DNK333, a potent, selective, non-peptide dual NK1/NK2 receptor antagonist

✍ C.A. Lewis; A.Z. El-Hashim; M. Gerspacher; K. Hoshiko; L. Mazzoni; H.-J. Pfannku 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract The airways' pharmacology of DNK333 ((1R,3R,2E)‐N‐[3,4‐dichlorobenzyl)]‐4‐[(hexahydro‐2‐oxo‐1H‐azepin‐3‐yl)amino]‐N‐methyl‐3,5bis(trifluoromethyl) benzamide), a potent and selective dual NK~1~/NK~2~ neurokinin receptor antagonist is described in the present paper. DNK333 bound with high

Identification, biological characterizat

Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate

✍ Di Fabio, Romano; Alvaro, Giuseppe; Braggio, Simone; Carletti, Renzo; Gerrard, P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 878 KB